Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Allarity Therapeutics (ALLR) FCF Margin (2024 - 2025)

Allarity Therapeutics' FCF Margin history spans 2 years, with the latest figure at 5496.61% for Q4 2025.

  • For Q4 2025, FCF Margin rose 122194.0% year-over-year to 5496.61%; the TTM value through Dec 2025 reached 8010.81%, up 535354.0%, while the annual FY2025 figure was 4633.75%, N/A changed from the prior year.
  • FCF Margin reached 5496.61% in Q4 2025 per ALLR's latest filing, down from 5982.46% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 45675.0% in Q2 2025 to a low of 1371.57% in Q1 2024.